In chronic lymphocytic leukemia (CLL), ZNF224 acts as a direct transcriptional activator of the cyclin D3 gene, thus exerting an important role in cell growth and drug resistance [31]. This evidence concerns the gene ZNF224 and B-cell chronic lymphocytic leukemia.